Home>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>E-64
E-64 Catalog No.GC13418

Cysteine protease inhibitor,irriversible

Size Price Stock Qty
10mM (in 1mL DMSO)
$42.00
In stock
5mg
$38.00
In stock
25mg
$99.00
In stock
100mg
$308.00
In stock
250mg
$730.00
In stock

Customer Review

Based on customer reviews.

Tel: (626) 353-8530 Email: sales@glpbio.com

Sample solution is provided at 25 µL, 10mM.

Quality Control

Quality Control & SDS

View current batch:

Protocol

Cell experiment: [1]

Cell lines

H-59 and M-27 cells

Preparation method

The solubility of this compound in DMSO is ≥53.6mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months.

Reaction Conditions

10 μg/ml , 48 hours

Applications

E-64 inhibited H-59 invasion in a dose-dependent manner with a maximal inhibition of 97% at a concentration of 10 μg/ml which was non-toxic. Cell migration as measured with filters coated with 7.5 μg/filter type IV collagen was reduced by only 25% suggesting that the cysteine proteinases played a more minor role in cell migration in the absence of a basement membrane barrier. On the other hand M-27 invasion was not significantly affected by treatment with E-64 even at concentrations as high as 100 μg/ml.

Animal experiment: [2]

Animal models

Wistar strain rats

Dosage form

Intraperitoneal injection, 1 mg/100 g body weight

Applications

The animals were killed 1 h after the injection and the cathepsin B and cathepsin L activities in the lysosomal were assayed. The inhibition caused by E-64 was already detectable 1 hour after its injection.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1] Navab R, Mort J S, Brodt P. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Clinical & experimental metastasis, 1997, 15(2): 121-129.

[2] Hashida S, TOWATARI T, KOMINAMI E, et al. Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. Journal of biochemistry, 1980, 88(6): 1805-1811.

Chemical Properties

Cas No. 66701-25-5 SDF
Synonyms N/A
Chemical Name (2S,3S)-3-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid
Canonical SMILES CC(C)CC(C(=O)NCCCCN=C(N)N)NC(=O)C1C(O1)C(=O)O
Formula C15H27N5O5 M.Wt 357.41
Solubility ≥53.6mg/mL in DMSO Storage Store at 2-8°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
  • Molarity Calculator

  • Dilution Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

Background

A new class of compounds that show promise of acting as class-specific inhibitors for the cysteine proteinases are the L-trans-epoxysuccinylpeptides related to the compound E-64 [L-trans-epoxysuccinyl-L-leucylamido(4-guanidino)butanel , isolated from cultures of Aspergillus. E-64 was shown to inhibit papain, ficin and the fruit and stem bromelains, with disappearance of the thiol group of papain1.

 E-64 has been reported to inhibit two other mammalian cysteine proteinases: cathepsin L3 and a proteinase from human breast-tumour tissue4 and the calcium-dependent proteinase, calpain, from chicken muscle5. All of these characteristics suggested that E-64 might be a valuable inhibitor for the study of cysteine proteinases.

Lineweaver-Burk plots of inhibition data show that the action of E-64 was not competitive with substrate1 . Moreover, the optical isomerism of the epoxysuccinyl moiety seemed to have no effect on the activity of E-64 as an inhibitor of papain6, 7 .If E-64 were indeed acting by covalent reaction at the active site, its rate of reaction would be decreased by the presence of leupeptin, a tight-binding reversible inhibitor8.

E-64 inhibits only cysteine proteinases. Papain showed a particularly high reactivity with E-64, and good rates were also obtained with the other plant enzymes and the lysosomal cysteine proteinases. There is structural evidence that these enzymes form a homologous group9, and they resemble each other in having Mr about 25 000, no (detected) zymogens and no distinct requirement for calcium. Chicken skeletal-muscle calpain is reported to be inhibited by E-64, but the rate constant has not been determined5.

The most obvious practical application of E-64 is in the active-site titration of the papain-related cysteine proteinases. Active-site titration as a method of determining enzyme concentration has the advantage over rate assays of being insensitive to reaction conditions, and giving a result in active-site molarity10 (Bender et al., 1966).

References:
1. A. J. BARRETT, A. A. KEMBHAVI, L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. (1982) 201, 189-198
2. Hanada, K., Tamai, M., Yamagishi, M., Ohmura, S., Sawada, J. & Tanaka, I. (1978c) Agric. Biol. Chem. 42, 523-528
3. Towatari, T., Tanaka, K., Yoshikawa, D. & Katunuma, N. (1978).J. Biochem. (Tokyo) 84, 659-671.
4. Mort, J. S., Recklies, A. D. & Poole, A. R. (1980) Biochim. Biophys. Acta 614, 134-143.
5. Sugita, H., Ishiura, S., Suzuki, K. & Imahori, K. (1980) J. Biochem. (Tokyo) 87, 339-341
6. Hanada, K., Tamai, M., Morimoto, S., Adachi, T.,Ohmura, S., Sawada, J. & Tanaka, I. (1978a) Agric. Biol. Chem. 42, 537-541.
7. Hanada, K., Tamai, M., Ohmura, S., Sawada, J., Seki, T.& Tanaka, I. (1978b)Agric. Biol. Chem. 42, 529-536
8. Knight, C. G. (1980) Biochem. J. 189,447-453
9. Takio, K., Towatari, T., Katunuma, N. & Titani, K.(1980) Biochem. Biophys. Res. Commun. 97, 340-346
10. Bender, M. L., Begue-Canton, M. L., Blakeley, R. L.,Brubacher, L. J., Feder, J., Gunter, C. R., Kezdy, F. J.,Killheffer, J. V., Marshall, T. H., Miller, C. G., Roeske,R. W. & Stoops, J. K. (1966) J. Am. Chem. Soc. 88,5890-5913